I have to pull you up on one aspect of your comment - the...

I have to pull you up on one aspect of your comment - the clinical trial and the suggestion that TIS didn't make it big enough to satisfy the regulator.

In yesterday's announcement, it was indicated that the EMA are convinced of the effectiveness of the product. So it's something else, which we have no information/detail on. Speculation here has been some theoretical possibility within the manufacturing process which has not been tested adequately yet.

I think the announcement in direction for the company this year, pursuing FDA approval, is a good thing. There is a lot of investment opportunity in the US and maybe more companies/people/funds willing to take a risk than say the EU or Australia. That's what has made the internet startup industry so huge in the US.